These antibodies had been found out using the proprietary monoclonal antibody proteomics system developed by BSI. The brand new diagnostic check provides hope to an incredible number of patients all over the world as it could detect the condition at an early on stage when medical intervention continues to be possible, increasing the probabilities for survival dramatically. A simple noninvasive blood check for the first detection of lung malignancy gets the potential to significantly raise the survival rate, saving many lives and considerably lowering the monetary burden to society..The studies, published in the January issue of AIDS Patient Treatment and STDs, involved experienced physicians in the USA highly, Canada and Italy who utilized the machine to help them select the optimum combination of HIV drugs for individuals whose therapy was failing. The HIV Treatment Response Prediction Program harnesses the power of complex computer models that have been qualified with data from a large number of patients all over the world. A prototype version of HIV-TRePS predicted the way the patient would react to hundreds of alternative combinations of HIV drugs.